|
Indianapolis, Ind., March 5, 2004
Roche Diagnostics Named Best in People Development
Company Debuts on Training Magazine's Top 100 "Best Lists"
Indianapolis, Ind. - based Roche Diagnostics, the number one
in vitro diagnostics company in the United States, today announced
that it has been named to Training magazine's Top 100 list
for excellence in developing its people. The company ranked #24
and was recognized as "best in class" in the healthcare
industry. More than 550 companies applied for the distinction.
Roche knows that people drive its business and has created an environment
where people can continually develop their capabilities and are
rewarded for their individual and collective contributions. An individual
development plan combined with on-the-job and formal training opportunities
are state-of-the-art and powerful approaches to people development.
"Roche Diagnostics' development programs demonstrate an impressive
connection to its business goals and performance," said Tammy
Galvin, Editor in Chief, Training magazine. "As the
highest ranking new company on this year's list, Roche Diagnostics
is a supreme example of a company that fosters people's learning,
development and relationships within the company. Through its comprehensive
workforce development programs, Roche clearly understands that the
ultimate prosperity of the organization is directly related to the
extent that people are encouraged to develop their own potential.
What's more, Roche does a phenomenal job of ensuring that all of
those development initiatives are tied to real business results."
Over the last several years, Roche Diagnostics has invested in
training and development programs for its 3,500 people who are located
in Indianapolis and remote locations throughout the U.S. In 2003,
Roche launched a new learning system, titled "myLEARNINGlink"
to broaden the scope and increase the efficiency and effectiveness
of its training and development opportunities. This recognition
reinforces Roche's outstanding work in continuing market leadership
through leveraging innovative training and development as a foundation
of its business strategy.
Roche's Training 100 award began with a nomination by one
of Roche's training providers, Acclivus Corporation, who developed
a specialized field customer service training program called R3
Service® (results, relationships and revenue) for Roche's Service
organization. Acclivus nominated Roche Diagnostics because of its
unparalleled dedication in introducing and continued support of
the successful completion of R3 Service®.
"We are thrilled to receive the nomination and award that
honors our commitment to investing in our people." said Raymond
Young, Jr., Vice President of Roche Diagnostics Services. "This
commendation also points to our dedication to provide exceptional
service and satisfaction for our customers. Roche's training and
development programs provide value and are vitally important to
our company, our customers and the individual, covering all facets
of our business."
The ranking for the Training Top 100 is based on factors such as:
" Financial investment in employee development,
" Type and scope of training and development programs provided
" Quality of programs, and
" How closely development efforts are linked to business goals
and objectives.
" For more information, please visit www.trainingmag.com
About Roche and the Roche Diagnostics Division
Headquartered in Basel, Switzerland, Roche is one of the world's
leading innovation-driven healthcare groups. Its core businesses
are pharmaceuticals and diagnostics. Roche is number one in the
global diagnostics market, the leading supplier of pharmaceuticals
for cancer and a leader in virology and transplantation. As a supplier
of products and services for the prevention, diagnosis and treatment
of disease, the Group contributes on a broad range of fronts to
improving people's health and quality of life. Roche employs roughly
65,000 people in 150 countries. The Group has alliances and research
and development agreements with numerous partners, including majority
ownership interests in Genentech and Chugai. Roche's Diagnostics
Division, the world leader in in-vitro diagnostics with a
uniquely broad product portfolio, supplies a wide array of innovative
testing products and services to researchers, physicians, patients,
hospitals and laboratories world-wide. Roche Diagnostics' North
American headquarters is located in Indianapolis, Ind. (www.roche-diagnostics.us).
For further information, please visit our websites www.roche.us
and www.roche-diagnostics.com.
For additional information contact:
Lori LeRoy
Roche Diagnostics
Tel.: +1-317-521-7159
e-mail: lori.leroy@roche.com
www.roche-diagnostics.us
|
